Nifty

:

24894.25

Sensex

:

81207.17

57.95 (0.23%)
223.86 (0.28%)

Login

Nifty
Sensex

:
:

24894.25
81207.17

57.95 (0.23%)
223.86 (0.28%)

Tatva Chintan Pharma Chem Ltd.

Chemicals

Rating :

47/99

BSE: 543321 | NSE: TATVA

Watchlist

NSE BSE

1028.10

01-Oct-2025

Open
High
Low
Previous Close

1010.1
1041.8
1003
1011.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

31463
32426420.4
1232.75
621

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,402.95
335.84
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,425.24
0.10%
3.22

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.08
4.97
-3.33

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.77
-12.38
-10.74

PAT CAGR (%)

10 Years
5 Years
3 Years

-26.76
-35.78
-49.93

P:E (Median)

8 Years
5 Years
3 Years

-
-
87.23

P:BV (Average)

8 Years
5 Years
3 Years

-
-
5.04

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
47.32

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 109.18 93.81 16.38% 107.65 93.93 14.61% 84.00 86.07 -2.41% 80.96 92.57 -12.54%
Expenses 94.11 86.11 9.29% 99.75 79.73 25.11% 78.35 73.76 6.22% 76.36 71.83 6.31%
EBITDA 15.07 7.70 95.71% 7.90 14.20 -44.37% 5.65 12.31 -54.10% 4.60 20.74 -77.82%
EBIDTM 13.80% 8.20% 7.34% 15.12% 6.72% 14.31% 5.68% 22.41%
Other Income 1.37 1.42 -3.52% 1.29 4.53 -71.52% 0.04 1.21 -96.69% 0.81 0.76 6.58%
Interest 0.41 0.31 32.26% 0.39 0.22 77.27% 0.42 0.38 10.53% 0.17 3.01 -94.35%
Depreciation 8.97 6.66 34.68% 7.26 6.23 16.53% 6.92 6.58 5.17% 6.81 6.78 0.44%
PBT 7.05 2.14 229.44% 1.55 12.28 -87.38% -1.65 6.56 - -1.58 11.71 -
Tax 1.92 0.63 204.76% 0.46 4.03 -88.59% -0.49 1.91 - -0.47 3.50 -
PAT 5.13 1.51 239.74% 1.09 8.25 -86.79% -1.17 4.65 - -1.11 8.20 -
PATM 4.70% 1.61% 1.02% 8.78% -1.39% 5.40% -1.37% 8.86%
EPS 2.19 0.64 242.19% 0.47 3.52 -86.65% -0.50 1.99 - -0.47 3.51 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 116.86 105.46 10.81% 107.86 98.27 9.76% 85.90 84.21 2.01% 83.49 96.67 -13.63%
Expenses 99.53 92.85 7.19% 98.91 82.66 19.66% 78.84 73.21 7.69% 77.90 76.42 1.94%
EBITDA 17.33 12.62 37.32% 8.95 15.61 -42.66% 7.06 10.99 -35.76% 5.59 20.25 -72.40%
EBIDTM 14.83% 11.96% 8.30% 15.88% 8.22% 13.06% 6.69% 20.95%
Other Income 1.16 1.17 -0.85% 0.72 4.53 -84.11% 0.04 1.21 -96.69% 0.38 0.76 -50.00%
Interest 0.41 0.31 32.26% 0.39 0.21 85.71% 0.42 0.38 10.53% 0.17 3.01 -94.35%
Depreciation 8.97 6.67 34.48% 7.26 6.23 16.53% 6.92 6.58 5.17% 6.81 6.78 0.44%
PBT 9.10 6.81 33.63% 2.03 13.69 -85.17% -0.24 5.24 - -1.02 11.21 -
Tax 2.45 1.60 53.12% 1.00 4.08 -75.49% -0.37 1.79 - -0.36 3.43 -
PAT 6.65 5.21 27.64% 1.03 9.61 -89.28% 0.14 3.45 -95.94% -0.66 7.78 -
PATM 5.69% 4.94% 0.95% 9.78% 0.16% 4.10% -0.80% 8.05%
EPS 2.84 2.23 27.35% 0.44 4.11 -89.29% 0.06 1.48 -95.95% -0.28 3.33 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 16 Mar 15 Mar 14
Net Sales 381.79 366.42 378.68 403.04 427.81 291.19 253.84 202.90 89.93 101.57 80.35 Net Sales Growth 4.21% -3.24% -6.04% -5.79% 46.92% 14.71% 25.11% 125.62% -11.46% 26.41% Cost Of Goods Sold 200.61 197.66 168.04 222.33 196.45 148.33 130.13 115.18 47.95 63.68 49.91 Gross Profit 181.18 168.75 210.64 180.72 231.36 142.86 123.71 87.72 41.98 37.89 30.43 GP Margin 47.46% 46.05% 55.62% 44.84% 54.08% 49.06% 48.74% 43.23% 46.68% 37.30% 37.87% Total Expenditure 348.57 340.41 311.66 348.23 321.81 225.79 201.14 169.71 75.09 90.30 69.62 Power & Fuel Cost - 34.44 34.78 23.61 22.62 9.92 8.96 6.25 1.53 3.25 2.91 % Of Sales - 9.40% 9.18% 5.86% 5.29% 3.41% 3.53% 3.08% 1.70% 3.20% 3.62% Employee Cost - 52.92 54.76 41.21 30.82 23.80 20.53 16.31 6.97 8.13 4.39 % Of Sales - 14.44% 14.46% 10.22% 7.20% 8.17% 8.09% 8.04% 7.75% 8.00% 5.46% Manufacturing Exp. - 30.99 32.04 30.72 42.30 26.38 23.99 13.88 3.18 6.37 4.28 % Of Sales - 8.46% 8.46% 7.62% 9.89% 9.06% 9.45% 6.84% 3.54% 6.27% 5.33% General & Admin Exp. - 10.42 10.99 10.33 9.10 6.88 5.96 7.57 3.53 1.71 1.40 % Of Sales - 2.84% 2.90% 2.56% 2.13% 2.36% 2.35% 3.73% 3.93% 1.68% 1.74% Selling & Distn. Exp. - 12.59 9.18 15.61 19.52 9.72 9.66 8.56 0.00 1.48 1.61 % Of Sales - 3.44% 2.42% 3.87% 4.56% 3.34% 3.81% 4.22% 0% 1.46% 2.00% Miscellaneous Exp. - 1.39 1.88 4.42 1.01 0.76 1.91 1.96 11.93 5.68 1.61 % Of Sales - 0.38% 0.50% 1.10% 0.24% 0.26% 0.75% 0.97% 13.27% 5.59% 6.37% EBITDA 33.22 26.01 67.02 54.81 106.00 65.40 52.70 33.19 14.84 11.27 10.73 EBITDA Margin 8.70% 7.10% 17.70% 13.60% 24.78% 22.46% 20.76% 16.36% 16.50% 11.10% 13.35% Other Income 3.51 3.56 7.51 5.68 10.63 5.10 0.56 0.44 0.78 1.43 0.13 Interest 1.39 1.45 6.66 8.52 5.19 4.41 4.25 3.94 1.79 2.47 2.13 Depreciation 29.96 27.65 25.60 9.55 8.18 6.73 4.79 4.01 2.19 1.86 0.83 PBT 5.37 0.46 42.27 42.42 103.27 59.35 44.22 25.68 11.63 8.37 7.89 Tax 1.42 0.13 12.92 -1.63 7.28 7.99 9.25 6.24 4.21 2.72 2.67 Tax Rate 26.44% 28.26% 30.57% -4.20% 7.05% 13.46% 20.92% 23.61% 36.20% 32.50% 33.84% PAT 3.94 0.33 29.35 40.47 95.99 51.36 34.96 20.19 7.43 5.65 5.23 PAT before Minority Interest 3.94 0.33 29.35 40.47 95.99 51.36 34.96 20.19 7.43 5.65 5.23 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.03% 0.09% 7.75% 10.04% 22.44% 17.64% 13.77% 9.95% 8.26% 5.56% 6.51% PAT Growth -82.57% -98.88% -27.48% -57.84% 86.90% 46.91% 73.16% 171.74% 31.50% 8.03% EPS 1.68 0.14 12.54 17.29 41.02 21.95 14.94 8.63 3.18 2.41 2.24

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 394.11 382.71 393.50 423.61 433.65 300.36 263.24 206.31 Net Sales Growth 2.47% -2.74% -7.11% -2.32% 44.38% 14.10% 27.59% Cost Of Goods Sold 200.28 198.94 174.18 226.10 194.64 152.00 132.77 114.24 Gross Profit 193.83 183.77 219.32 197.51 239.01 148.35 130.47 92.07 GP Margin 49.18% 48.02% 55.74% 46.63% 55.12% 49.39% 49.56% 44.63% Total Expenditure 355.18 348.28 325.11 362.83 325.13 233.68 207.96 172.19 Power & Fuel Cost - 34.44 34.78 23.61 22.62 9.92 8.96 6.25 % Of Sales - 9.00% 8.84% 5.57% 5.22% 3.30% 3.40% 3.03% Employee Cost - 52.92 54.76 41.21 30.82 23.80 20.53 16.31 % Of Sales - 13.83% 13.92% 9.73% 7.11% 7.92% 7.80% 7.91% Manufacturing Exp. - 30.99 32.04 30.72 42.30 26.38 24.00 13.88 % Of Sales - 8.10% 8.14% 7.25% 9.75% 8.78% 9.12% 6.73% General & Admin Exp. - 11.15 11.82 11.29 9.76 7.21 6.58 8.06 % Of Sales - 2.91% 3.00% 2.67% 2.25% 2.40% 2.50% 3.91% Selling & Distn. Exp. - 18.44 14.67 20.95 23.87 13.56 11.88 11.13 % Of Sales - 4.82% 3.73% 4.95% 5.50% 4.51% 4.51% 5.39% Miscellaneous Exp. - 1.40 2.87 8.94 1.13 0.80 3.24 2.32 % Of Sales - 0.37% 0.73% 2.11% 0.26% 0.27% 1.23% 1.12% EBITDA 38.93 34.43 68.39 60.78 108.52 66.68 55.28 34.12 EBITDA Margin 9.88% 9.00% 17.38% 14.35% 25.02% 22.20% 21.00% 16.54% Other Income 2.30 2.31 7.51 5.74 9.02 5.20 1.38 0.49 Interest 1.39 1.51 6.73 8.60 5.23 4.45 4.27 3.95 Depreciation 29.96 27.66 25.61 9.55 8.18 6.73 4.79 4.02 PBT 9.87 7.58 43.57 48.37 104.12 60.70 47.60 26.64 Tax 2.72 1.87 13.21 -0.71 8.25 8.43 9.81 6.85 Tax Rate 27.56% 24.67% 30.32% -1.59% 7.92% 13.89% 20.61% 25.01% PAT 7.16 5.71 30.35 45.49 95.87 52.26 37.79 20.54 PAT before Minority Interest 7.16 5.71 30.35 45.49 95.87 52.26 37.79 20.54 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.82% 1.49% 7.71% 10.74% 22.11% 17.40% 14.36% 9.96% PAT Growth -72.51% -81.19% -33.28% -52.55% 83.45% 38.29% 83.98% EPS 3.06 2.44 12.97 19.44 40.97 22.33 16.15 8.78

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 14 Mar 13 Mar 12
Shareholder's Funds 721.31 725.88 504.78 468.88 161.94 114.45 79.64 15.93 10.36 8.27 Share Capital 23.39 23.39 22.16 22.16 20.09 8.04 8.04 4.36 4.00 3.73 Total Reserves 697.92 702.49 482.62 446.71 141.85 106.41 71.60 11.57 6.36 4.54 Non-Current Liabilities -10.86 -10.32 -11.03 5.06 30.82 43.59 35.16 8.29 7.49 7.89 Secured Loans 0.00 0.64 4.23 13.11 26.76 38.71 31.52 1.71 1.76 2.56 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.29 4.58 4.37 Long Term Provisions 1.40 1.33 1.15 0.65 0.55 0.40 0.29 0.00 0.00 0.00 Current Liabilities 100.09 87.21 246.58 193.55 127.08 87.26 72.57 28.54 20.79 17.65 Trade Payables 32.31 44.26 31.61 44.06 47.04 31.23 22.05 14.28 6.95 7.03 Other Current Liabilities 31.61 32.59 56.55 56.66 20.39 15.49 10.57 0.46 0.54 0.44 Short Term Borrowings 35.75 10.00 156.21 92.47 49.29 40.49 39.91 13.80 13.30 10.16 Short Term Provisions 0.42 0.36 2.21 0.37 10.35 0.06 0.04 0.00 0.00 0.01 Total Liabilities 810.54 802.77 740.33 667.49 319.84 245.30 187.37 52.76 38.64 33.81 Net Block 528.66 426.87 196.22 159.61 120.45 111.18 66.71 12.20 11.02 10.91 Gross Block 617.18 488.00 231.75 186.14 138.88 122.48 73.45 15.71 13.97 13.15 Accumulated Depreciation 88.52 61.13 35.53 26.53 18.43 11.30 6.74 3.51 2.95 2.24 Non Current Assets 559.03 509.16 430.85 214.37 131.22 116.90 73.78 15.09 13.80 13.36 Capital Work in Progress 24.31 76.54 230.74 51.49 9.81 4.89 6.04 0.20 0.00 0.01 Non Current Investment 0.67 0.67 0.67 0.67 0.67 0.67 0.67 0.00 0.00 0.00 Long Term Loans & Adv. 4.28 4.26 2.66 2.09 0.30 0.17 0.38 2.68 2.77 2.45 Other Non Current Assets 1.11 0.83 0.55 0.51 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 251.52 293.61 309.49 453.12 188.61 128.40 113.58 37.44 24.69 20.39 Current Investments 0.00 10.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 123.30 144.11 151.45 160.69 68.36 58.72 31.06 10.86 7.40 6.77 Sundry Debtors 76.16 67.95 90.04 61.60 90.34 50.97 44.65 18.89 11.99 8.64 Cash & Bank 11.93 36.97 38.58 174.74 3.59 9.82 15.66 2.58 1.54 1.23 Other Current Assets 40.13 6.68 5.09 5.37 26.33 8.89 22.20 5.12 3.76 3.75 Short Term Loans & Adv. 33.90 27.85 24.32 50.72 19.92 6.04 18.55 5.12 3.76 3.75 Net Current Assets 151.43 206.39 62.91 259.57 61.54 41.14 41.01 8.91 3.90 2.74 Total Assets 810.55 802.77 740.34 667.49 319.83 245.30 187.36 52.75 38.65 33.81

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 738.82 737.08 514.79 473.09 165.96 117.69 79.70 Share Capital 23.39 23.39 22.16 22.16 20.09 8.04 8.04 Total Reserves 715.43 713.69 492.63 450.92 145.88 109.66 71.67 Non-Current Liabilities -11.23 -10.32 -11.03 5.06 30.82 43.59 35.16 Secured Loans 0.00 0.64 4.23 13.11 26.76 38.71 31.52 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.40 1.33 1.15 0.65 0.55 0.40 0.29 Current Liabilities 96.12 79.78 240.57 171.20 128.41 87.65 72.65 Trade Payables 32.69 45.03 32.19 44.51 47.48 31.61 22.13 Other Current Liabilities 25.15 24.19 49.75 33.01 20.74 15.49 10.57 Short Term Borrowings 35.75 10.00 156.21 92.47 49.29 40.49 39.91 Short Term Provisions 2.53 0.56 2.43 1.20 10.89 0.06 0.04 Total Liabilities 823.71 806.54 744.33 649.35 325.19 248.93 187.51 Net Block 528.68 426.89 196.25 159.61 120.45 111.18 66.71 Gross Block 617.21 488.02 231.78 186.14 138.88 122.48 73.46 Accumulated Depreciation 88.53 61.14 35.53 26.53 18.44 11.30 6.74 Non Current Assets 558.38 508.51 430.20 213.71 130.55 116.24 73.12 Capital Work in Progress 24.31 76.54 230.74 51.49 9.81 4.89 6.04 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 4.28 4.26 2.66 2.09 0.30 0.17 0.38 Other Non Current Assets 1.11 0.83 0.55 0.51 0.00 0.00 0.00 Current Assets 265.33 298.03 314.13 435.64 194.64 132.70 114.38 Current Investments 0.00 10.05 0.00 0.00 0.00 0.00 0.00 Inventories 133.95 152.77 162.50 169.96 72.02 63.55 35.59 Sundry Debtors 82.53 69.85 84.40 56.60 90.74 49.57 41.26 Cash & Bank 14.10 38.29 44.76 176.99 5.34 10.83 15.74 Other Current Assets 34.76 6.80 5.13 5.38 26.54 8.74 21.79 Short Term Loans & Adv. 28.33 20.27 17.34 26.72 20.16 5.89 18.14 Net Current Assets 169.22 218.24 73.56 264.44 66.23 45.05 41.73 Total Assets 823.71 806.54 744.33 649.35 325.19 248.94 187.50

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 23.91 102.78 23.73 19.76 18.91 24.64 7.87 3.29 2.50 0.00 PBT 0.46 42.27 38.83 103.27 59.35 44.22 26.43 7.89 2.71 0.00 Adjustment 28.34 28.17 15.82 9.64 6.92 8.20 7.49 1.89 1.66 0.00 Changes in Working Capital -0.46 38.81 -23.18 -75.18 -37.55 -20.40 -20.31 -3.97 -1.17 0.00 Cash after chg. in Working capital 28.34 109.25 31.47 37.73 28.73 32.02 13.61 5.82 3.20 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.44 -6.47 -7.74 -17.97 -9.82 -7.39 -5.74 -2.53 -0.70 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -65.25 -120.54 -101.12 -196.69 -20.61 -40.18 -16.77 -2.58 -1.08 0.00 Net Fixed Assets -76.95 -102.05 -224.86 -88.94 -21.32 -47.88 -63.58 -1.94 -0.81 -2.53 Net Investments 10.05 -10.05 0.00 0.00 0.00 0.00 -0.67 0.00 0.00 0.00 Others 1.65 -8.44 123.74 -107.75 0.71 7.70 47.48 -0.64 -0.27 2.53 Cash from Financing Activity 16.57 30.54 37.81 235.01 -4.72 9.70 17.40 0.33 -1.10 0.00 Net Cash Inflow / Outflow -24.78 12.78 -39.58 58.08 -6.42 -5.85 8.50 1.04 0.31 0.00 Opening Cash & Equivalents 33.99 21.19 60.77 2.73 9.15 15.66 7.17 1.54 1.23 0.00 Closing Cash & Equivalent 9.21 33.99 21.19 60.77 2.73 9.82 15.66 2.58 1.54 0.00

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 24.67 98.04 27.78 20.23 19.69 25.31 7.36 PBT 7.58 43.57 44.78 104.12 60.70 47.60 27.39 Adjustment 29.31 28.60 16.69 11.63 6.85 8.56 7.57 Changes in Working Capital -7.72 34.44 -24.40 -77.11 -38.04 -22.64 -21.66 Cash after chg. in Working capital 29.17 106.61 37.07 38.64 29.50 33.51 13.31 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.50 -8.56 -9.29 -18.41 -9.81 -8.20 -5.95 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -65.25 -120.54 -101.14 -196.69 -20.66 -40.18 -16.77 Net Fixed Assets -76.95 -102.05 -224.86 -88.94 -21.32 -47.88 Net Investments 10.05 -10.05 0.00 0.00 0.00 0.00 Others 1.65 -8.44 123.72 -107.75 0.66 7.70 Cash from Financing Activity 16.57 30.52 37.80 235.01 -4.71 9.95 17.40 Net Cash Inflow / Outflow -24.02 8.02 -35.57 58.55 -5.67 -4.92 7.99 Opening Cash & Equivalents 35.30 27.36 63.02 4.48 10.16 15.74 7.76 Closing Cash & Equivalent 11.37 35.30 27.36 63.02 4.48 10.83 15.74

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 308.36 310.31 227.74 211.54 80.61 56.97 99.11 36.03 25.52 21.99 ROA 0.04% 3.80% 5.75% 19.44% 18.18% 16.16% 12.10% 11.44% 5.02% 6.20% ROE 0.05% 4.77% 8.31% 30.43% 37.16% 36.03% 28.76% 40.35% 19.75% 24.48% ROCE 0.26% 6.91% 7.49% 25.79% 27.88% 26.78% 22.19% 29.77% 16.80% 21.57% Fixed Asset Turnover 0.66 1.06 1.93 2.63 2.23 2.59 2.84 5.42 3.89 4.04 Receivable days 71.70 75.93 68.49 64.78 88.57 68.75 72.32 70.03 71.31 49.67 Inventory Days 133.04 142.05 140.96 97.66 79.65 64.54 49.92 41.43 48.99 50.55 Payable days 70.69 82.40 62.12 84.63 96.30 48.79 51.46 4651.92 3411.13 3207.32 Cash Conversion Cycle 134.05 135.59 147.33 77.81 71.91 84.50 70.78 -4540.46 -3290.84 -3107.10 Total Debt/Equity 0.05 0.02 0.34 0.26 0.56 0.79 0.97 1.32 1.92 2.08 Interest Cover 1.32 7.35 5.56 20.90 14.45 11.40 7.71 4.98 2.41 2.43

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 315.84 315.10 232.25 213.44 82.62 58.59 99.19 ROA 0.70% 3.91% 6.53% 19.68% 18.21% 17.32% 12.28% ROE 0.77% 4.85% 9.21% 30.01% 36.85% 38.29% 28.95% ROCE 1.19% 7.00% 8.35% 25.75% 28.04% 28.40% 22.78% Fixed Asset Turnover 0.69 1.10 2.03 2.67 2.30 2.69 2.88 Receivable days 72.59 71.34 60.72 61.98 85.26 62.97 64.50 Inventory Days 136.58 145.79 143.16 101.78 82.38 68.74 57.57 Payable days 71.30 80.91 61.91 86.25 94.96 48.09 50.05 Cash Conversion Cycle 137.87 136.22 141.97 77.51 72.67 83.61 72.03 Total Debt/Equity 0.05 0.02 0.33 0.25 0.54 0.77 0.97 Interest Cover 6.01 7.47 6.21 20.90 14.65 12.15 7.94

Top Investors:

nippon life india trustee ltd-a/c nippon india elss tax saver fund

goldman sachs funds - goldman sachs india equity portfolio

icici prudential smallcap fund

mukul mahavir agrawal

Annual Reports:

News Update:

Tatva Chintan Pharma - Quarterly Results
24th Jul 2025, 15:40 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback